HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Metabolic effects of 1-week binge drinking and fast food intake during Roskilde Festival in young healthy male adults.

AbstractAIMS/HYPOTHESIS:
Metabolic effects of intermittent unhealthy lifestyle in young adults are poorly studied. We investigated the gluco-metabolic and hepatic effects of participation in Roskilde Festival (1 week of binge drinking and junk food consumption) in young, healthy males.
METHODS:
Fourteen festival participants (FP) were studied before, during and after 1 week's participation in Roskilde Festival. Fourteen matched controls (CTRL) who did not participate in Roskilde Festival or change their lifestyle in other ways were investigated along a similar timeline.
RESULTS:
The FP group consumed more alcohol compared to their standard living conditions (2.0 ± 3.9 vs 16.3 ± 8.3 units/day, P < 0.001). CTRLs did not change their alcohol consumption. AUC for glucose during OGTT did not change in either group. C-peptide responses increased in the FP group (206 ± 24 vs 236 ± 17 min × nmol/L, P = 0.052) and the Matsuda index of insulin sensitivity decreased (6.2 ± 2.4 vs 4.7 ± 1.4, P = 0.054). AUC for glucagon during oral glucose tolerance test (OGTT) increased in the FP group (1037 ± 90 vs 1562 ± 195 min × pmol/L, P = 0.003) together with fasting fibroblast growth factor 21 (FGF21) (62 ± 30 vs 132 ± 72 pmol/L, P < 0.001), growth differentiation factor 15 (GDF5) (276 ± 78 vs 330 ± 83 pg/mL, P = 0.009) and aspartate aminotransferase (AST) levels (37.6 ± 6.8 vs 42.4 ± 11 U/L, P = 0.043). Four participants (29%) developed ultrasound-detectable steatosis and a mean strain elastography-assessed liver stiffness increased (P = 0.026) in the FP group.
CONCLUSIONS/INTERPRETATION:
Participation in Roskilde Festival did not affect oral glucose tolerance but was associated with a reduction in insulin sensitivity, increases in glucagon, FGF21, GDF15 and AST and lead to increased liver stiffness and, in 29% of the participants, ultrasound-detectable hepatic steatosis.
AuthorsMia Demant, Malte P Suppli, Signe Foghsgaard, Lise Gether, Magnus F G Grøndahl, Niels B Dalsgaard, Sigrid S Bergmann, Amalie R Lanng, Lærke S Gasbjerg, Martin Thomasen, Jonatan I Bagger, Charlotte Strandberg, Merete J Kønig, Henning Grønbæk, Ulrik Becker, Nicolai J Wewer Albrechtsen, Jens J Holst, Joachim Knop, Matthew P Gillum, Tina Vilsbøll, Filip K Knop
JournalEuropean journal of endocrinology (Eur J Endocrinol) Vol. 185 Issue 1 Pg. 23-32 (May 21 2021) ISSN: 1479-683X [Electronic] England
PMID33886497 (Publication Type: Journal Article)
Chemical References
  • Blood Glucose
  • C-Peptide
  • FGF21 protein, human
  • GDF15 protein, human
  • Growth Differentiation Factor 15
  • Fibroblast Growth Factors
  • C-Reactive Protein
  • Glucagon
  • Aspartate Aminotransferases
Topics
  • Adult
  • Aspartate Aminotransferases (metabolism)
  • Binge Drinking (metabolism)
  • Blood Glucose (metabolism)
  • C-Peptide (metabolism)
  • C-Reactive Protein (metabolism)
  • Denmark
  • Diet
  • Elasticity Imaging Techniques
  • Fast Foods
  • Fatty Liver (diagnostic imaging, metabolism)
  • Fibroblast Growth Factors (metabolism)
  • Glucagon (metabolism)
  • Glucose Tolerance Test
  • Growth Differentiation Factor 15 (metabolism)
  • Holidays
  • Humans
  • Insulin Resistance
  • Liver (diagnostic imaging)
  • Male
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: